Hematopoietic Stem Cell Transplantation—50 Years of Evolution and Future Perspectives

Hematopoietic Stem Cell Transplantation—50 Years of Evolution and Future Perspectives

Hematopoietic stem cell transplantation is a highly specialized and unique medical procedure. Autologous transplantation allows the administration of high-dose chemotherapy without prolonged bone marrow aplasia. In allogeneic transplantation, donor-derived stem cells provide alloimmunity that enable...

Full description

Bibliographic Details
Main Authors:	Israel Henig, Tsila Zuckerman
Format:	Article
Language:	English
Published:	Rambam Health Care Campus 2014-10-01
Series:	Rambam Maimonides Medical Journal
Subjects:	Adoptive immunotherapy alternative donor conditioning graft-versus-host disease graft-versus-leukemia hematopoietic stem cell transplantation
Online Access:	http://rmmj.org.il/Pages/ArticleHTM.aspx?manuId=444

Similar Items

Donor γδT Cells Promote GVL Effect and Mitigate aGVHD in Allogeneic Hematopoietic Stem Cell Transplantation
by: Yuan Song, et al.
Published: (2020-10-01)

Sphingolipid metabolism in T cell responses after allogeneic hematopoietic cell transplantation
by: Linlu Tian, et al.
Published: (2022-08-01)

Immune reconstitution after hematopoietic stem cell transplantation
by: Justyna Ogonek, et al.
Published: (2016-11-01)

Is It Possible to Separate the Graft-Versus-Leukemia (GVL) Effect Against B Cell Acute Lymphoblastic Leukemia From Graft-Versus-Host Disease (GVHD) After Hematopoietic Cell Transplant?
by: Jacob Rozmus, et al.
Published: (2022-03-01)

Mouse Models of Antigen Presentation in Hematopoietic Stem Cell Transplantation
by: Motoko Koyama, et al.
Published: (2021-09-01)

Unrelated umbilical cord blood can improve the prognosis of haploidentical hematopoietic stem cell transplantation
by: Ying Yang, et al.
Published: (2022-09-01)

Mesenchymal stem cell-derived exosomes can alleviate GVHD and preserve the GVL effect in allogeneic stem cell transplantation animal models
by: Yan Jiang, et al.
Published: (2023-12-01)

Regulatory T-cells and allogeneic hematopoietic stem cell transplantation
by: O. S. Karavaeva, et al.
Published: (2022-12-01)

Advancing Allogeneic Hematopoietic Stem Cell Transplantation Outcomes through Immunotherapy: A Comprehensive Review of Optimizing Non-CAR Donor T-Lymphocyte Infusion Strategies
by: Stefania Braidotti, et al.
Published: (2024-08-01)

Editorial: Recent Developments in Haploidentical Hematopoietic Cell Transplantation: Therapy and Complications
by: Ying-Jun Chang, et al.
Published: (2021-08-01)

Efficacy and safety of prophylactic modified donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia
by: YANG Luxin, et al.
Published: (2019-12-01)

Scabies mimicking graft versus host disease in a hematopoietic cell transplant recipient
by: Dongsub Kim, et al.
Published: (2018-11-01)

The late outcomes of syngeneic hematopoietic stem cell transplantation in patients with blood disorders
by: A. A. Dmitrova, et al.
Published: (2022-11-01)

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ADULT PATIENTS WITH FANCONI ANEMIA.
by: hosein kamranzadeh fumani, et al.
Published: (2016-11-01)

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN FANCONI ANEMIA; A SINGLE CENTRE EXPERIENCE
by: Tariq Azam Khattak, et al.
Published: (2021-02-01)

The Role of Immune Checkpoint Molecules for Relapse After Allogeneic Hematopoietic Cell Transplantation
by: Natalie Köhler, et al.
Published: (2021-03-01)

Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin in Patients with Hematological Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Haploidentical and Matched Unrelated Donors: A Real-Life Experience
by: Bianca Serio, et al.
Published: (2024-04-01)

Naive T Cells in Graft Versus Host Disease and Graft Versus Leukemia: Innocent or Guilty?
by: Linde Dekker, et al.
Published: (2022-06-01)

A comprehensive model to predict severe acute graft-versus-host disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantation
by: Meng-Zhu Shen, et al.
Published: (2022-05-01)

Hematopoietic Stem Cells Transplant (HSCT)-Related Chronic Pulmonary Diseases: An Overview
by: Arianna Traunero, et al.
Published: (2023-09-01)

Alterations of Peripheral Blood T Cell Subsets following Donor Lymphocyte Infusion in Patients after Allogeneic Stem Cell Transplantation
by: Ann-Kristin Schmaelter, et al.
Published: (2021-11-01)

Allogeneic DNT cell therapy synergizes with T cells to promote anti-leukemic activities while suppressing GvHD
by: Jongbok Lee, et al.
Published: (2025-01-01)

Acute Complications of Pediatric Allogeneic Hematopoietic Stem Cell Transplantation and Their Effects on Survival: A Single-Center Experience in Korea
by: Kyoung Min Lee, et al.
Published: (2023-04-01)

Ocular graft-versus-host disease: An update on immune pathogenesis and therapies
by: Samantha P. Peña-Lozano, et al.
Published: (2022-07-01)

Anti-monocyte globulin in allogeneic transplantation of hematopoietic stem cells
by: Yu. R. Zalyalov, et al.
Published: (2022-11-01)

Case report: Donor lymphocyte infusion and blinatumomab as treatment for acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation
by: Flavia Antonucci, et al.
Published: (2024-03-01)

Current Approaches for the Prevention and Treatment of Acute and Chronic GVHD
by: Attilio Olivieri, et al.
Published: (2024-09-01)

Pericardial effusion and cardiac tamponade: clinical manifestation of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
by: David Cavalcanti Ferreira, et al.
Published: (2014-04-01)

Culture-Expanded Human Invariant Natural Killer T Cells Suppress T-Cell Alloreactivity and Eradicate Leukemia
by: Hannes Schmid, et al.
Published: (2018-08-01)

Disseminated cutaneous infection due to Mycobacterium chelonae following hematopoietic stem cell transplantation
by: C. Ferry, et al.
Published: (2014-01-01)

Acquisition and Cure of Autoimmune Disease Following Allogeneic Hematopoietic Stem Cell Transplantation
by: Hsin-An Hou, et al.
Published: (2007-09-01)

Effectiveness of T-Cell Replete Haploidentical Hematopoietic Stem Cell Transplantation for Refractory/Relapsed B Cell Acute Lymphoblastic Leukemia in Children and Adolescents
by: Hideki Sano, et al.
Published: (2021-10-01)

Hematopoietic Stem Cell Transplantation in Adult Sickle Cell Disease: Problems and Solutions
by: Hakan Özdoğu, et al.
Published: (2015-07-01)

Mucosal-associated invariant T cells predict increased acute graft-versus-host-disease incidence in patients receiving allogeneic hematopoietic stem cell transplantation
by: Zhao Wang, et al.
Published: (2022-09-01)

Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysis
by: Michael Stadler, et al.
Published: (2022-08-01)

T-Cell Metabolism in Hematopoietic Cell Transplantation
by: Hung D. Nguyen, et al.
Published: (2018-02-01)

The impact of the donors’ COVID-19 status on the outcomes of allogeneic hematopoietic stem cell transplantation: a multi-center retrospective study
by: Yifei Huang, et al.
Published: (2024-07-01)

Dermoscopy of Cutaneous Graft-Versus-Host-Disease in Patients After Allogeneic Hematopoietic Stem Cell Transplantation
by: Grażyna Kaminska-Winciorek, et al.
Published: (2020-07-01)

Clinical Aspects Of Sclerodermatous Type Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation
by: Hatice Şanlı, et al.
Published: (2010-06-01)

Clinical aspects of sclerodermatous type graft-versus-host disease after allogeneic hematopoietic cell transplantation
by: Hatice Şanlı, et al.
Published: (2010-06-01)